Better Therapy, Care in Advanced Breast Cancer Has Led to Longer SurvivalBetter Therapy, Care in Advanced Breast Cancer Has Led to Longer Survival
(MedPage Today) — Patients newly diagnosed with advanced breast cancer in 2025 would be expected to live 7 months longer on average than they did 15 years ago, according to an analysis of U.S. data.
Comparing 2011-2013 to 2020-2022, the overall…
Why More Women Are Facing Breast Cancer in Pregnancy and PostpartumWhy More Women Are Facing Breast Cancer in Pregnancy and Postpartum
These cases can be difficult to find and even harder to safely treat.
Promising drug can inhibit aggressive breast cancerPromising drug can inhibit aggressive breast cancer
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 InhibitorHopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor
(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting. Spearheading… (MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially Read More
Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical GuidanceUse of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance
(MedPage Today) — Prescriptions for GLP-1 receptor agonists for patients with cancer have increased despite a lack of clinical guidance on the drugs’ safety and efficacy in cancer, a large retrospective review of health records showed.
Overall…
Does Microdosing GLP-1s Work? Expert Weighs InDoes Microdosing GLP-1s Work? Expert Weighs In
(MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. More companies are promoting microdosing GLP-1 receptor agonists even… (MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on Read More
Breast cancer relapse: Key cellular resistance mechanism discoveredBreast cancer relapse: Key cellular resistance mechanism discovered
Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to therapeutic combinations of chemotherapy, but a tiny minority of tumor cells may manage to tolerate these treatments. These so-called “persister” cells are then able to reform a tumor, causing a relapse of breast cancer in 20 to 30% of cases.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancerStudy shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth International Consensus Conference (ABC8).
Cancer Drugs, Anti-Obesity Pill Secure FDA Expedited Review VouchersCancer Drugs, Anti-Obesity Pill Secure FDA Expedited Review Vouchers
(MedPage Today) — The FDA announced six more awardees for the FDA Commissioner’s National Priority Voucher (CNPV) pilot program designed to accelerate approval of drugs that address unmet needs or whose makers have agreed to specific criteria…
Some Patients Can Maintain Health Gains After Reducing GLP-1 Dose FrequencySome Patients Can Maintain Health Gains After Reducing GLP-1 Dose Frequency
(MedPage Today) — Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements in weight, body composition, and metabolic improvements after they reduced the… (MedPage Today) — Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor Read More